Grommes C, Nayak L, Kallam A, Peereboom D, et al. Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial. Blood 2026 Oct 1:blood.2026034926. doi: 10.1182/blood.2026034926.
PMID: 42821736